Cargando…
Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA
One of the strategies for curing viral HIV-1 is a therapeutic vaccine involving the stimulation of cytotoxic CD8-positive T cells (CTL) that are Human Leucocyte Antigen (HLA)-restricted. The lack of efficiency of previous vaccination strategies may have been due to the immunogenic peptides used, whi...
Autores principales: | Tumiotto, Camille, Riviere, Lionel, Bellecave, Pantxika, Recordon-Pinson, Patricia, Vilain-Parce, Alice, Guidicelli, Gwenda-Line, Fleury, Hervé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608338/ https://www.ncbi.nlm.nih.gov/pubmed/28934310 http://dx.doi.org/10.1371/journal.pone.0185211 |
Ejemplares similares
-
Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles
por: Tumiotto, Camille, et al.
Publicado: (2019) -
Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study
por: Papuchon, Jennifer, et al.
Publicado: (2014) -
Molecular Characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and Impact of T-Cell Epitope Mutations on HLA Recognition (ANRS 12159)
por: Lazaro, Estibaliz, et al.
Publicado: (2011) -
ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study)
por: Fleury, Hervé, et al.
Publicado: (2020) -
Resistance Mutations and CTL Epitopes in Archived HIV-1 DNA of Patients on Antiviral Treatment: Toward a New Concept of Vaccine
por: Papuchon, Jennifer, et al.
Publicado: (2013)